Dr. Reddy’s gets DCGI nod for use of Zytorvi in esophageal cancer
Dr. Reddy’s Laboratories Dr. Reddy’s Laboratories has received Central Drugs Standard Control Organisation (CDSCO) approval for the use of Zytorvi (toripalimab) in the treatment of unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC). Also Read | Dr. Reddy’s CDMO arm Aurigene inks long-term manufacturing pact with global pharma major The approval from the…
Read More “Dr. Reddy’s gets DCGI nod for use of Zytorvi in esophageal cancer” »